Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

The role of respiratory viruses in the transmission of Streptococcus pneumoniae is poorly understood. Key questions, such as which serotypes are most fit for transmission and disease and whether influenza virus alters these parameters in a serotype-specific manner, have not been adequately studied. In a novel model of transmission in ferrets, we demonstrated that pneumococcal transmission and disease were enhanced if donors had previously been infected with influenza virus. Bacterial titers in nasal wash, the incidence of mucosal and invasive disease, and the percentage of contacts that were infected all increased. In contact ferrets, viral infection increased their susceptibility to S. pneumoniae acquisition both in terms of the percentage infected and the distance over which they could acquire infection. These influenza-mediated effects on colonization, transmission, and disease were dependent on the pneumococcal strain. Overall, these data argue that the relationship between respiratory viral infections, acquisition of pneumococci, and development of disease in humans needs further study to be better understood.

[1]  Ron Dagan,et al.  Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  K. Auranen,et al.  Pneumococcal Acute Otitis Media in Relation to Pneumococcal Nasopharyngeal Carriage , 2005, The Pediatric infectious disease journal.

[3]  S. Normark,et al.  Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae. , 2009, The Journal of infectious diseases.

[4]  Kelli L Boyd,et al.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. , 2007, Cell host & microbe.

[5]  B. Gray,et al.  Clinical and epidemiologic studies of pneumococcal infection in children , 1986, Pediatric infectious disease.

[6]  R. Rappuoli,et al.  Clonal success of piliated penicillin nonsusceptible pneumococci , 2007, Proceedings of the National Academy of Sciences.

[7]  J. McCullers,et al.  Novel Strategy to Prevent Otitis Media Caused by Colonizing Streptococcus pneumoniae , 2007, PLoS Pathogens.

[8]  A. Sandgren,et al.  Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. , 2004, The Journal of infectious diseases.

[9]  J. McCullers.  Insights into the Interaction between Influenza Virus and Pneumococcus , 2006, Clinical Microbiology Reviews.

[10]  A. M. Collier,et al.  A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. , 1982, The New England journal of medicine.

[11]  J. McCullers,et al.  Respiratory viruses predisposing to bacterial infections: role of neuraminidase , 2004, The Pediatric infectious disease journal.

[12]  M. Sande,et al.  Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. , 1975, The Journal of infectious diseases.

[13]  B. Gray,et al.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.

[14]  M. Lonetto,et al.  A functional genomic analysis of type 3 Streptococcus pneumoniae virulence , 2001, Molecular microbiology.

[15]  S. Normark,et al.  Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. , 2005, The Journal of infectious diseases.

[16]  J. McCullers,et al.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.

[17]  M. Pichichero,et al.  How to compare the efficacy of conjugate vaccines to prevent acute otitis media? , 2009, Vaccine.

[18]  A. Camilli,et al.  Large‐scale identification of serotype 4 Streptococcus pneumoniae virulence factors , 2002, Molecular microbiology.

[19]  J. Rehg,et al.  Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets , 2006, Infection and Immunity.

[20]  M. Finland.  RECENT ADVANCES IN THE EPIDEMIOLOGY OF PNEUMOCOCCAL INFECTIONS , 1942 .

[21]  J. Rehg,et al.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. , 2002, The Journal of infectious diseases.

[22]  J. Rehg,et al.  Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. , 2007, Comparative medicine.

[23]  Marc Lipsitch,et al.  Visualizing Pneumococcal Infections in the Lungs of Live Mice Using Bioluminescent Streptococcus pneumoniaeTransformed with a Novel Gram-Positive luxTransposon , 2001, Infection and Immunity.

[24]  D. Isaacman,et al.  Streptococcus pneumoniae: Description of the Pathogen, Disease Epidemiology, Treatment, and Prevention , 2005, Pharmacotherapy.

[25]  D. Simon,et al.  Large-Scale Identification of Virulence Genes fromStreptococcus pneumoniae , 1998, Infection and Immunity.